Primary |
Product Used For Unknown Indication |
55.9% |
Depression |
11.8% |
Panic Disorder |
6.6% |
Anxiety |
4.6% |
Schizophrenia |
3.9% |
Autism |
3.3% |
Drug Use For Unknown Indication |
2.0% |
Insomnia |
2.0% |
Depressed Mood |
1.3% |
Ill-defined Disorder |
1.3% |
Premature Ejaculation |
1.3% |
Anaesthesia |
0.7% |
Chemotherapy |
0.7% |
Encephalopathy |
0.7% |
Incorrect Dose Administered |
0.7% |
Major Depression |
0.7% |
Obsessive-compulsive Disorder |
0.7% |
Pain |
0.7% |
Panic Attack |
0.7% |
Post-traumatic Stress Disorder |
0.7% |
|
Toxicity To Various Agents |
33.3% |
Foetal Exposure During Pregnancy |
5.1% |
Maternal Drugs Affecting Foetus |
5.1% |
Panic Attack |
5.1% |
Psychotic Disorder |
5.1% |
Serotonin Syndrome |
5.1% |
Sopor |
5.1% |
Suicide Attempt |
5.1% |
Accidental Exposure To Product |
2.6% |
Acute Generalised Exanthematous Pustulosis |
2.6% |
Blindness Unilateral |
2.6% |
Completed Suicide |
2.6% |
Drug Abuse |
2.6% |
Exposure During Pregnancy |
2.6% |
Fall |
2.6% |
Fatigue |
2.6% |
Foreign Body |
2.6% |
Hepatotoxicity |
2.6% |
Infertility Male |
2.6% |
Intentional Drug Misuse |
2.6% |
|
Secondary |
Product Used For Unknown Indication |
46.1% |
Ill-defined Disorder |
16.3% |
Depression |
5.7% |
Bipolar Disorder |
3.5% |
Convulsion |
3.5% |
Anxiety |
2.8% |
Drug Use For Unknown Indication |
2.8% |
Insomnia |
2.8% |
Psychotic Disorder |
2.8% |
Accidental Exposure To Product By Child |
2.1% |
Suicide Attempt |
2.1% |
Drug Use For Unknown Indication |
1.4% |
Antidepressant Therapy |
1.4% |
Anxiolytic Therapy |
1.4% |
Schizophrenia, Paranoid Type |
1.4% |
Compulsions |
0.7% |
Obsessive-compulsive Disorder |
0.7% |
Atrial Fibrillation |
0.7% |
Back Pain |
0.7% |
Hypertension |
0.7% |
|
Toxicity To Various Agents |
21.2% |
Cardio-respiratory Arrest |
6.1% |
Mydriasis |
6.1% |
Respiratory Arrest |
6.1% |
Sopor |
6.1% |
Substance Abuse |
6.1% |
Suicide Attempt |
6.1% |
Visceral Congestion |
6.1% |
Completed Suicide |
3.0% |
Disease Progression |
3.0% |
Female Sexual Arousal Disorder |
3.0% |
Insomnia |
3.0% |
Medication Error |
3.0% |
Multiple Drug Overdose Intentional |
3.0% |
Parkinsonism |
3.0% |
Pemphigoid |
3.0% |
Poisoning |
3.0% |
Pregnancy |
3.0% |
Respiratory Acidosis |
3.0% |
Speech Disorder |
3.0% |
|
Concomitant |
Pain |
13.7% |
Chronic Paroxysmal Hemicrania |
11.8% |
Plasma Cell Myeloma |
9.8% |
Product Used For Unknown Indication |
9.8% |
Diabetes Mellitus |
7.8% |
Neuralgia |
5.9% |
Epilepsy |
3.9% |
Hypertension |
3.9% |
Ill-defined Disorder |
3.9% |
Irritable Bowel Syndrome |
3.9% |
Migraine |
3.9% |
Multiple Sclerosis |
3.9% |
Tuberous Sclerosis |
3.9% |
Drug Use For Unknown Indication |
2.0% |
Throat Infection |
2.0% |
Age-related Macular Degeneration |
2.0% |
Antibiotic Prophylaxis |
2.0% |
Arthralgia |
2.0% |
Bipolar Disorder |
2.0% |
Chronic Myeloid Leukaemia |
2.0% |
|
Therapeutic Response Unexpected |
15.4% |
Pancreatitis Relapsing |
7.7% |
Vomiting |
7.7% |
White Blood Cell Count Decreased |
7.7% |
Anaphylactic Reaction |
3.8% |
Angioedema |
3.8% |
Congestive Cardiomyopathy |
3.8% |
Depression |
3.8% |
Diarrhoea |
3.8% |
Diverticulitis |
3.8% |
Drug Ineffective |
3.8% |
Dysarthria |
3.8% |
Flatulence |
3.8% |
Gastric Ulcer |
3.8% |
Headache |
3.8% |
Hypertension |
3.8% |
Hypoglycaemia |
3.8% |
International Normalised Ratio Increased |
3.8% |
Malaise |
3.8% |
Methaemoglobinaemia |
3.8% |
|